Skip to main content
CMPS
NASDAQ Life Sciences

COMP360 Shows Durable 52-Week Efficacy in Phase 3 COMP005; Stock Jumps 11%

Tom Rudovsky · Reported by Benzinga
More coverage: Healthcare Facility Stocks · Healthcare
Sentiment info
Positive
Importance info
8
Price
$15.295
Mkt Cap
$1.944B
52W Low
$4.82
52W High
$15.87
52W Position info
217% above low
Off High info
3.6% below high
Rel. Volume info
1.4× avg
Market data snapshot near publication time

CMPS has more than doubled off its 52-week low of $4.82.

Summary

Compass Pathways released 52-week Part C data from its Phase 3 COMP005 trial of COMP360 in treatment-resistant depression. The open-label extension showed a 13-point MADRS reduction in the 25 mg arm and a 10-point reduction in placebo crossovers, with 40-45% response and ~30% remission rates. No new safety signals. The stock rose over 11% on the news. This follows the positive 26-week COMP006 data from July and supports the rolling NDA submission, expected to complete in Q4 2026, with a potential launch in H1 2027. The durability data strengthens the commercial case for COMP360 and de-risks the regulatory path.

At the time of this announcement, CMPS was trading at $15.30 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $1.9B. The 52-week trading range was $4.82 to $15.87. This news item was assessed with positive market sentiment and an importance score of 8 out of 10. Source: Benzinga.


Price Chart

Share this article

Copied!

CMPS - Latest Insights

CMPS
Nov 09, 2026, 6:30 AM EST
Source: BusinessWire
Importance Score:
8
Price at Filing: $8.90
Real-time Price: $8.06 info
Change: -$0.840 (-9%) info
Market Cap: $1.131B info
CMPS
Nov 03, 2026, 8:07 AM EST
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $9.21
Real-time Price: $8.06 info
Change: -$1.15 (-12%) info
Market Cap: $1.131B info
CMPS
Nov 03, 2026, 6:30 AM EST
Source: BusinessWire
Importance Score:
7
Price at Filing: $9.50
Real-time Price: $8.06 info
Change: -$1.44 (-15%) info
Market Cap: $1.131B info
CMPS
Sep 23, 2026, 3:15 AM EDT
Source: Wiseek News
Importance Score:
7
Price at Filing: $14.75
Real-time Price: $8.06 info
Change: -$6.69 (-45%) info
Market Cap: $1.131B info
CMPS
Aug 05, 2026, 6:30 AM EDT
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $11.84
Real-time Price: $8.06 info
Change: -$3.78 (-32%) info
Market Cap: $1.131B info